Clinical Trials
70 trialsPRIORITY-CONNECT 2 Pilot Trial
Surgical Outcomes Research Centre (SOuRCe)
Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.
Taipei Veterans General Hospital, Taiwan
Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Gastrectomy
Azienda Ospedaliera Universitaria Integrata Verona
RRTGS
First Affiliated Hospital Xi'an Jiaotong University
Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors
Nanjing First Hospital, Nanjing Medical University
Application of IPC During Surgery to Prevent Venous Thrombosis in Gastrointestinal Surgery Patients.
Shandong Provincial Hospital
CLDN18.2 Targeting PET Imaging in Patients With Gastrointestinal Tumors
Peking University Cancer Hospital & Institute
Prevention of Neuropathic Pain From Oxaliplatin by Photobiomodulation
Saint-Gregoire Private Hospital Center
Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project
University Hospital, Ghent
ROME
Fondazione per la Medicina Personalizzata
Adapting the Tumor Board Model for Mental Illness and Cancer
Massachusetts General Hospital
Use of DRS Probe and Tracking for In-vivo Application
Imperial College London
68Ga-PMD22 PET/CT Examination Targeting CLDN18.2
Peking Union Medical College Hospital
ICG-COLORAL
Oulu University Hospital
Immunological Variables Associated to ICI Toxicity in Cancer Patients
Jules Bordet Institute
A Single-Arm Phase II Exploratory Clinical Study of Pemigatinib in the Treatment of Advanced Gastrointestinal Cancer (Excluding Biliary Tract Cancer) Patients With FGFR Alterations Who Have Failed Standard Therapy
Zhejiang Cancer Hospital
Effects of Different Doses of Vitamin D on Cancer-related Cognitive Impairment in Patients With Gastrointestinal Tumors
Yangzhou University
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors
Silverback Therapeutics
Endoscopic Vital Nerve Staining in Gastrointestinal Diseases
Affiliated Hospital to Academy of Military Medical Sciences
PTC in Personalizing Neoadjuvant Therapy for Patients With Advanced Gastrointestinal Tumor
Peking University
An Exploratory Trail of Camrelizumab Plus Apatinib Mesylate for Advanced Gastrointestinal
Harbin Medical University
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
Curegenix Inc.
ALDHCRF
Korea University Anam Hospital
X7-7
University of Kansas Medical Center
Management of Oxaliplatin-related Gastroesophageal Variceal Bleeding
Shanghai Zhongshan Hospital
PENDICOQ
University Hospital, Strasbourg, France
RusGCG-01
Blokhin's Russian Cancer Research Center
Macroscopic on Cite Evaluation of EUS-FNA Specimen With 22 G Needle
Kocaeli University
IMPROVED
Assistance Publique - Hôpitaux de Paris
Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses
Charite University, Berlin, Germany
Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors
Curegenix Inc.
Oncogeriatric Intervention and Follow-up at Home
University of Aarhus
PICaSO
Mount Sinai Hospital, Canada
MMIPC
Radboud University Medical Center
A Questionnaire for Endoscopic Prediction Improvement of Gastrointestinal Cancer
Shandong University
HIPEC/IPHC
Bay Area Gynecology Oncology
Sensitivity and Specificity of NGS in Detecting bMSI in Patients With Gastric, Duodenal and Small Intestinal Cancer
China Medical University, China
The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer
Fudan University
EMERGE
Royal Marsden NHS Foundation Trust
Efficacy and Safety of a Preoperative Aerobic Exercise Program in Patients With Gastrointestinal Cancer.
Instituto Nacional de Cancerologia, Columbia
Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)
Shenzhen People's Hospital
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
Royal Marsden NHS Foundation Trust
M14AFS
The Netherlands Cancer Institute
NSTBIPAGC
First Affiliated Hospital Xi'an Jiaotong University
Clinical Research on Teratment of Gastrointestinal Cancer in the Preoperative by Propranolol
Central South University
Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Gastrointestinal Cancer
Hangzhou Converd Co., Ltd.
Clinical Trial of Electroacupuncture Stimulation on Prevention and Treatment of Oxaliplatin Neurotoxicity
The First Affiliated Hospital of Dalian Medical University
A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC
Sun Yat-sen University
Tamoxifen in Patients With Oesophageal Cancer
University of Nottingham